Grail (GRAL) Share-based Compensation (2023 - 2026)
Grail's (GRAL) quarterly Share-based Compensation came in at $28.3 million in Q2 2026, up 100.07% on a YoY basis from $14.2 million in Q2 2025, and up 68.8% quarter-over-quarter from $16.8 million in Q1 2026.
Analysis
Grail (GRAL) Share-based Compensation (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Share-based Compensation for 4 consecutive years, with $28.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation rose 100.07% year-over-year to $28.3 million; the trailing twelve-month figure through Jun 2026 stood at $73.0 million (up 18.94% YoY), and the FY2025 full-year result was $58.3 million, down 32.3% from the prior year.
- Share-based Compensation rose to $28.3 million in Q2 2026 per GRAL's latest filing, from $16.8 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $97.0 million in Q4 2023 and bottomed at $13.6 million in Q4 2024.
- Historically, Share-based Compensation has averaged $26.0 million across 4 years, with a median of $16.8 million in 2026.
- The sharpest annual moves came in 2024 and 2026: Share-based Compensation plunged 86.0% in 2024, then soared 100.07% in 2026.
- Over 4 years, Share-based Compensation stood at $97.0 million in 2023, then slumped by 86.0% to $13.6 million in 2024, then gained by 1.35% to $13.8 million in 2025, then soared by 105.93% to $28.3 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $28.3 million, $16.8 million, and $13.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 103.10 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 6.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 26.80 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 57.73 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 54.12 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 22.22 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 7.38 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 8.22 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 11.12 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 28.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.35 Mn |
| Mar 31, 2026 | 16.79 Mn |
| Dec 31, 2025 | 13.77 Mn |
| Sep 30, 2025 | 14.14 Mn |
| Jun 30, 2025 | 14.17 Mn |
| Mar 31, 2025 | 16.21 Mn |
| Dec 31, 2024 | 13.58 Mn |
| Sep 30, 2024 | 17.45 Mn |
| Jun 30, 2024 | 25.95 Mn |
| Mar 31, 2024 | 29.11 Mn |
| Dec 31, 2023 | 97.02 Mn |